Tompkins Financial Corp Gsk PLC Transaction History

Tompkins Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $94,741 - $112,427	2,355 Added 147.19%	3,955 $173,000
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $15,365 - $18,012	-451 Reduced 21.99%	1,600 $59,000
Q4 2020 Feb 05, 2021	BUY	$34.07 - $39.94 $5,144 - $6,030	151 Added 7.95%	2,051 $78,000
Q2 2020 Jul 29, 2020	SELL	$37.87 - $43.58 $3,786 - $4,358	-100 Reduced 5.0%	1,900 $78,000
Q1 2020 Apr 22, 2020	BUY	$32.47 - $48.83 $9,741 - $14,649	300 Added 17.65%	2,000 $76,000
Q4 2019 Jan 22, 2020	BUY	$42.0 - $48.25 $54,600 - $62,725	1,300 Added 325.0%	1,700 $80,000
Q3 2019 Oct 17, 2019	SELL	$40.46 - $43.52 $13,028 - $14,013	-322 Reduced 44.6%	400 $17,000
Q1 2019 Apr 30, 2019	BUY	$38.57 - $42.69 $3,857 - $4,269	100 Added 16.08%	722 $30,000
Q2 2018 Jul 18, 2018	BUY	$39.61 - $42.76 $24,637 - $26,596	622 New	622 $25,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Tompkins Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Tompkins Financial Corp with notifications on news.